NicholasDonaldKlemenMD

PubMed

• 2 citations
  Local Therapy for Oligoprogression or Consolidation in High Mutational Burden Stage 4 Colorectal Cancer Treated With PD-1 or PD-L1 Blockade.
  Nicholas D Klemen, Colin M Court, Maria Clara Fernandes, Henry S Walch, Walid K Chatila, Steven Maron, Chris Crane, Jinru Shia, Andrea Cercek, Mithat Gönen, Nikolaus D...> ;Annals of Surgical Oncology. 2022 Dec 1
• ASO Author Reflections: How Immunotherapy Could Change the Management of Responsive Solid Tumors.
  Nicholas D Klemen, Michael I D'Angelica> ;Annals of Surgical Oncology. 2022 Dec 1
• 1 citations
  Correction: Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarc...
  Sanjay P Bagaria, Carol Swallow, Harini Suraweera, Chandrajit P Raut, Mark Fairweather, Ferdinando Cananzi, Vittorio Quagliuolo, Giovanni Grignani, Daphne Hompes, Samu...> ;Annals of Surgical Oncology. 2022 Mar 17
• 11 citations
  Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma.
  Nicholas D Klemen, Sinchun Hwang, Martina Bradic, Evan Rosenbaum, Mark A Dickson, Mrinal M Gounder, Ciara M Kelly, Mary L Keohan, Sujana Movva, Katherine A Thornton, P...> ;Clinical Cancer Research. 2022 Mar 1
• Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review.
  Feingold, P. L.,Klemen, N. D.,Kwong, MLM.,Hashimoto, B.,Rudloff, U.> ;Int J Hyperthermia. 2017 Dec 08
• Join now to see all